Differences in plasmatic and CSF Alzheimer's Disease biomarkers considering ApoE genotype in mild cognitive impairment and subjective cognitive decline
Plasmatic AD biomarkers did not differ regarding APOE genotype in our sample, but we find a difference in CSF biomarker and the APOE genotype. So, our findings confirm the influence of APOE ε4 allele in central nervous system amyloid levels.
Authors
- Isadora Cristina Ribeiro (ORCID: https://orcid.org/0000-0002-2433-1096)
- Brenda Costa Gonçalves
- Marjorie Cristina Rocha da Silva (ORCID: https://orcid.org/0000-0002-9005-2757)
- Ítalo Karmann Aventurato (ORCID: https://orcid.org/0000-0001-9314-1109)
- Liara Rizzi (ORCID: https://orcid.org/0000-0001-9823-8647)
- Gustavo Bruniera Peres Fernandes (ORCID: https://orcid.org/0000-0002-4459-5179)
- Ananssa Silva
- Thaís Lopes Pinheiro
- Marcio Luiz Figueredo Balthazar
- Luis E. Santos
- Fernanda G. De Felice
- Beatriz Ramos Lucente
Institutions
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Hospital Israelita Albert Einstein (BR)
- D’Or Institute for Research and Education (BR)
- Faculdade de Medicina de Jundiaí (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_104334
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00